ClearOne, Inc. Reports Third Quarter 2023 Financial Results
- Improved Production Output Drives Significant Reductions in Backlog -
- Sequential and Year-over-Year OpEx Reductions Reflect Continued Benefits of Cost Optimization Initiatives -
“In the third quarter, we continued ramping shipments for our leading communication solutions and operating from a leaner expense structure,” said
“Alongside our increased production, we also made steady progress with our cost optimization efforts, reducing operating expenses 3% sequentially and 16% year-over-year. With approximately
Operational Highlights
- Debuted new Versa USB22D Dante Adapter at InfoComm India 2023, enabling users to seamlessly connect computers to a Dante network and use any audio application for playback or capture without installing software.
-
DIALOG® UVHF Wireless Microphone System was named a winner of the 2023 AV Technology magazine Pro AV Best in Market award program and the 2023
Tech & Learning Magazine Awards of Excellence, highlighting the system’s innovative audio performance and adaptability. - Expanded the Company’s comprehensive portfolio of commercial and residential solutions to the D-Tools software platform for integrators. The D-Tools product library now features detailed information on ClearOne’s full line of communications, conferencing, and collaboration solutions and related accessory parts.
- Showcased a complete suite of collaboration, conferencing, and communication products and programs at CEDIA 2023. The display included the Versa® Mediabar™ video soundbar, the recently launched CHAT® 150 BT Speakerphone, UNITE® 60 4K ePTZ Wide-Angle Tracking Camera, COLLABORATE® Versa® Pro CT, COLLABORATE® Versa® Lite CT, and COLLABORATE® Versa® 60.
Graham continued: “Through and beyond the third quarter, we have continued launching new products and expanding the reach of our portfolio. In late October, we debuted our Versa® USB22D Dante® Adapter at InfoComm India 2023. This new product offers classrooms, businesses of all sizes, and residential customers seamless access to a Dante® network on any computer.
“Additionally, our DIALOG® UVHF Wireless Microphone System—which was just launched in June of this year—was recognized as a winner at both the 2023
“Moving into the fourth quarter, we are working to complete our manufacturing transition and drive greater market demand for ClearOne’s audio solutions. We are focused on generating sustainable revenue growth by ramping shipments of our BMA 360D and DIALOG® UVHF, as well as rolling out our remaining new product launches. With our expanding product library and optimized cost and capital structure, we aim to build upon the foundation we’ve laid to drive ongoing product innovation and expand our share of the AV market.”
Financial Summary
The Company uses certain non-GAAP financial measures and reconciles those to GAAP measures in the attached tables.
-
Q3 2023 revenue was
$4.9 million , compared to$6.3 million in Q3 2022 and$5.5 million in Q2 2023. The 11% sequential decrease was driven by reduced demand all product categories except our cameras. We believe the flow of sales orders at the end of Q3 2023 slowed down considerably due to the cumulative impact of past product shortages. The year-over-year decrease was mainly due to sustained inventory sourcing and order fulfillment challenges for the Company’s core audio conferencing and beamforming microphone arrays as a result of delays in the transition of outsourced manufacturing fromChina toSingapore . -
GAAP gross profit in Q3 2023 was
$1.6 million , compared to$2.6 million in Q3 2022 and$1.8 million in Q2 2023. GAAP gross profit margin was 33% in Q3 2023, compared to 34% in Q2 2023 and 41% in Q3 2022. Gross profit margin improved by approximately 100 basis points sequentially due to reduced inventory obsolescence costs. Gross profit margin decreased year-over-year due to increased administration and overhead costs as a percentage of revenue and change in the revenue mix of the products. -
Operating expenses in Q3 2023 improved to
$3.1 million , compared to$3.7 million in Q3 2022 and$3.2 million in Q2 2023. Non-GAAP operating expenses in Q3 2023 improved to$2.9 million compared to$3.1 million in Q2 2023 and$3.0 million in Q3 2022. The sequential and year-over-year decrease in non-GAAP operating expenses was mainly due to the continued benefits of the cost-cutting measures initiated in 2022. -
GAAP net loss in Q3 2023 was
$(1.4) million , or$(0.06) per share, compared to a net loss of$(1.2) million , or$(0.05) per share, in Q3 2022 and a net loss of$(1.0) million , or$(0.04) per share, in Q2 2023. The sequential and year-over-year increase in net loss was primarily due to the aforementioned decrease in revenue and gross profit, partially offset by a decrease in operating expenses and increase in interest income. -
Non-GAAP net loss in Q3 2023 was
$(1.2) million , or$(0.05) per share, compared to a Non-GAAP net loss of$(0.5) million , or$(0.02) per share, in Q3 2022 and a Non-GAAP net loss of$(0.9) million , or$(0.04) per share, in Q2 2023. The sequential and year-over-year increase in net losses were driven by the aforementioned decrease in revenue and gross profit partially offset by a decrease in operating expenses and increase in interest income.
($ in 000, except per share) |
Three months ended |
Nine months ended |
|||||||||||||||||||
|
2023 |
2022 |
Change in % Favorable/ (Adverse) |
2023 |
2022 |
Change in % Favorable/ (Adverse) |
|||||||||||||||
GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Revenue |
$ |
4,889 |
|
$ |
6,264 |
|
(22 |
) |
$ |
14,550 |
|
$ |
21,184 |
|
(31 |
) |
|||||
Gross profit |
|
1,616 |
|
|
2,570 |
|
(37 |
) |
|
4,779 |
|
|
8,193 |
|
(42 |
) |
|||||
Operating expenses |
|
3,105 |
|
|
3,700 |
|
16 |
|
|
9,812 |
|
|
12,825 |
|
23 |
|
|||||
Operating loss |
|
(1,489 |
) |
|
(1,130 |
) |
(32 |
) |
|
(5,033 |
) |
|
(4,632 |
) |
(9 |
) |
|||||
Net loss |
|
(1,351 |
) |
|
(1,248 |
) |
(8 |
) |
|
(3,202 |
) |
|
(3,472 |
) |
8 |
|
|||||
Diluted loss per share |
|
(0.06 |
) |
|
(0.05 |
) |
(20 |
) |
|
(0.13 |
) |
|
(0.15 |
) |
13 |
|
|||||
Non-GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Non-GAAP operating expenses |
$ |
2,933 |
|
$ |
2,992 |
|
2 |
$ |
9,349 |
|
$ |
10,704 |
|
13 |
|||||||
Non-GAAP operating loss |
|
(1,315 |
) |
|
(420 |
) |
(213 |
) |
|
(4,565 |
) |
|
(2,505 |
) |
(82 |
) |
|||||
Non-GAAP net loss |
|
(1,177 |
) |
|
(538 |
) |
(119 |
) |
|
(4,084 |
) |
|
(2,873 |
) |
(42 |
) |
|||||
Non-GAAP Adjusted EBITDA |
|
(1,006 |
) |
|
(360 |
) |
(179 |
) |
|
(3,395 |
) |
|
(2,321 |
) |
(46 |
) |
|||||
Non-GAAP diluted loss per share |
|
(0.05 |
) |
|
(0.02 |
) |
(150 |
) |
|
(0.17 |
) |
|
(0.12 |
) |
(42 |
) |
Balance Sheet Highlights
As of
Nasdaq Minimum Bid Price Requirement
On
In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from
About
Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a GAAP basis,
Forward Looking Statements
This release contains “forward-looking” statements that are based on present circumstances and on ClearOne’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements and any statements of the plans and objectives of management for future operations and forecasts of future growth and value and the possible outcomes of litigation, are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. Such forward-looking statements are made only as of the date of this release and
In particular, the financial information contained herein is subject to and qualified by reference to the financial statements contained in the 10-Q, including the footnotes thereto, as well as the Company’s annual report on Form 10-K for the year ended
|
|||||||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
(Dollars in thousands, except par value) |
|||||||
|
|||||||
|
|
|
|||||
ASSETS |
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
13,694 |
|
$ |
984 |
|
|
Current marketable securities |
|
5,698 |
|
|
— |
|
|
Legal settlement receivable |
|
— |
|
|
55,000 |
|
|
Receivables, net of allowance of |
|
3,874 |
|
|
3,603 |
|
|
Inventories, net |
|
8,664 |
|
|
8,961 |
|
|
Income tax receivable |
|
6,381 |
|
|
1,071 |
|
|
Prepaid expenses and other assets |
|
3,776 |
|
|
7,808 |
|
|
Total current assets |
|
42,087 |
|
|
77,427 |
|
|
Long-term marketable securities |
|
583 |
|
|
— |
|
|
Long-term inventories, net |
|
2,870 |
|
|
2,707 |
|
|
Property and equipment, net |
|
590 |
|
|
383 |
|
|
Operating lease - right of use assets, net |
|
1,081 |
|
|
1,047 |
|
|
Intangibles, net |
|
1,794 |
|
|
2,071 |
|
|
Other assets |
|
112 |
|
|
115 |
|
|
Total assets |
$ |
49,117 |
|
$ |
83,750 |
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
Accounts payable |
$ |
1,759 |
|
$ |
1,284 |
|
|
Accrued liabilities |
|
2,340 |
|
|
3,041 |
|
|
Deferred product revenue |
|
38 |
|
|
63 |
|
|
Short-term debt |
|
1,204 |
|
|
3,732 |
|
|
Total current liabilities |
|
5,341 |
|
|
8,120 |
|
|
Operating lease liability, net of current |
|
755 |
|
|
492 |
|
|
Other long-term liabilities |
|
1,008 |
|
|
1,008 |
|
|
Total liabilities |
|
7,104 |
|
|
9,620 |
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
Common stock, par value |
|
24 |
|
|
24 |
|
|
Additional paid-in capital |
|
46,015 |
|
|
74,910 |
|
|
Accumulated other comprehensive loss |
|
(308 |
) |
|
(288 |
) |
|
Accumulated deficit |
|
(3,718 |
) |
|
(516 |
) |
|
Total shareholders' equity |
|
42,013 |
|
|
74,130 |
|
|
Total liabilities and shareholders' equity |
$ |
49,117 |
|
$ |
83,750 |
|
|
|||||||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS |
|||||||||||||||
(Dollars in thousands, except per share amounts) |
|||||||||||||||
|
|||||||||||||||
|
Three months ended
|
Nine months ended
|
|||||||||||||
|
2023 |
2022 |
2023 |
2022 |
|||||||||||
Revenue |
$ |
4,889 |
|
$ |
6,264 |
|
$ |
14,550 |
|
$ |
21,184 |
|
|||
Cost of goods sold |
|
3,273 |
|
|
3,694 |
|
|
9,771 |
|
|
12,991 |
|
|||
Gross profit |
|
1,616 |
|
|
2,570 |
|
|
4,779 |
|
|
8,193 |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|||
Sales and marketing |
|
1,119 |
|
|
1,151 |
|
|
3,634 |
|
|
4,273 |
|
|||
Research and product development |
|
889 |
|
|
876 |
|
|
2,805 |
|
|
3,406 |
|
|||
General and administrative |
|
1,097 |
|
|
1,673 |
|
|
3,373 |
|
|
5,146 |
|
|||
Total operating expenses |
|
3,105 |
|
|
3,700 |
|
|
9,812 |
|
|
12,825 |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Operating loss |
|
(1,489 |
) |
|
(1,130 |
) |
|
(5,033 |
) |
|
(4,632 |
) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Interest expense |
|
(86 |
) |
|
(90 |
) |
|
(469) |
|
(285 |
) |
||||
Other income, net |
|
243 |
|
|
(3 |
) |
|
2,346 |
|
|
1,505 |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Loss before income taxes |
|
(1,332 |
) |
|
(1,223 |
) |
|
(3,156 |
) |
|
(3,412 |
) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Provision for income taxes |
|
19 |
|
|
25 |
|
|
46 |
|
|
60 |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Net loss |
$ |
(1,351 |
) |
$ |
(1,248 |
) |
$ |
(3,202 |
) |
$ |
(3,472 |
) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Basic weighted average shares outstanding |
|
23,960,313 |
|
|
23,952,555 |
|
|
23,957,311 |
|
|
23,933,033 |
|
|||
Diluted weighted average shares outstanding |
|
23,960,313 |
|
|
23,952,555 |
|
|
23,957,311 |
|
|
23,933,033 |
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Basic loss per share |
$ |
(0.06 |
) |
$ |
(0.05 |
) |
$ |
(0.13 |
) |
$ |
(0.15 |
) |
|||
Diluted loss per share |
$ |
(0.06 |
) |
$ |
(0.05 |
) |
$ |
(0.13 |
) |
$ |
(0.15 |
) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|||
Net loss |
$ |
(1,351 |
) |
$ |
(1,248 |
) |
$ |
(3,202 |
) |
$ |
(3,472 |
) |
|||
Unrealized loss on available-for-sale securities, net of tax |
|
(31 |
) |
|
— |
|
|
(17 |
) |
|
(2 |
) |
|||
Change in foreign currency translation adjustment |
|
(7 |
) |
|
(22 |
) |
|
(3 |
) |
|
(45 |
) |
|||
Comprehensive loss |
$ |
(1,389 |
) |
$ |
(1,270 |
) |
$ |
(3,222 |
) |
$ |
(3,519 |
) |
|
|||||||||||||||
UNAUDITED RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES |
|||||||||||||||
(Dollars in thousands, except per share values) |
|||||||||||||||
|
|||||||||||||||
|
Three months ended
|
Nine months ended
|
|||||||||||||
|
2023 |
2022 |
2023 |
2022 |
|||||||||||
GAAP operating loss |
$ |
(1,489 |
) |
$ |
(1,130 |
) |
$ |
(5,033 |
) |
$ |
(4,632 |
) |
|||
Stock-based compensation |
|
33 |
|
|
24 |
|
|
80 |
|
|
89 |
|
|||
Amortization of intangibles |
|
141 |
|
|
686 |
|
|
388 |
|
|
2,038 |
|
|||
Non-GAAP operating loss |
$ |
(1,315 |
) |
$ |
(420 |
) |
$ |
(4,565 |
) |
$ |
(2,505 |
) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
GAAP net loss |
$ |
(1,351 |
) |
$ |
(1,248 |
) |
$ |
(3,202 |
) |
$ |
(3,472 |
) |
|||
Stock-based compensation |
|
33 |
|
|
24 |
|
|
80 |
|
|
89 |
|
|||
Amortization of intangibles |
|
141 |
|
|
686 |
|
|
388 |
|
|
2,038 |
|
|||
Other income adjustment |
|
— |
|
|
— |
|
|
(1,350 |
) |
|
— |
|
|||
CARES Act PPP loan forgiveness |
|
— |
|
|
— |
|
— |
|
|
(1,528 |
) |
||||
Non-GAAP net loss |
$ |
(1,177 |
) |
$ |
(538 |
) |
$ |
(4,084 |
) |
$ |
(2,873 |
) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
GAAP net loss |
$ |
(1,351 |
) |
$ |
(1,248 |
) |
$ |
(3,202 |
) |
$ |
(3,472 |
) |
|||
Number of shares used in computing GAAP diluted loss per share |
|
23,960,313 |
|
|
23,952,555 |
|
|
23,957,311 |
|
|
23,933,033 |
|
|||
GAAP diluted loss per share |
$ |
(0.06 |
) |
$ |
(0.05 |
) |
$ |
(0.13 |
) |
$ |
(0.15 |
) |
|||
Non-GAAP net loss |
$ |
(1,177 |
) |
$ |
(538 |
) |
$ |
(4,084 |
) |
$ |
(2,873 |
) |
|||
Number of shares used in computing Non-GAAP diluted loss per share |
|
23,960,313 |
|
|
23,952,555 |
|
|
23,957,311 |
|
|
23,933,033 |
|
|||
Non-GAAP diluted loss per share |
$ |
(0.05 |
) |
$ |
(0.02 |
) |
$ |
(0.17 |
) |
$ |
(0.12 |
) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
GAAP net loss |
$ |
(1,351 |
) |
$ |
(1,248 |
) |
$ |
(3,202 |
) |
$ |
(3,472 |
) |
|||
Stock-based compensation |
|
33 |
|
|
24 |
|
|
80 |
|
|
89 |
|
|||
Interest expense |
|
86 |
|
|
90 |
|
|
469 |
|
285 |
|
||||
Depreciation |
|
66 |
|
|
63 |
|
|
174 |
|
|
207 |
|
|||
Amortization of intangibles |
|
141 |
|
|
686 |
|
|
388 |
|
|
2,038 |
|
|||
Other income adjustment |
|
— |
|
|
— |
|
|
(1,350 |
) |
|
— |
|
|||
CARES Act PPP loan forgiveness |
|
— |
|
|
— |
|
— |
|
|
(1,528 |
) |
||||
Provision for (benefit from) income taxes |
|
19 |
|
|
25 |
|
|
46 |
|
|
60 |
|
|||
Non-GAAP Adjusted EBITDA |
$ |
(1,006 |
) |
$ |
(360 |
) |
$ |
(3,395 |
) |
$ |
(2,321 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20231109998946/en/
385-426-0565
investor_relations@clearone.com
http://investors.clearone.com
Investor Relations Contact
Gateway Group, Inc.
949-574-3860
CLRO@gateway-grp.com
Source: